Judge Signs Off On Final Approval Of $73M Settlement For EpiPen Antitrust Claims
KANSAS CITY, Kan. — A Kansas federal judge on May 21 granted final approval to a $73 million settlement reached with Mylan NV, Mylan Specialty LP and Mylan Pharmaceuticals Inc. (collectively,...To view the full article, register now.
Already a subscriber? Click here to view full article